Teresa Amaral, MD, PhD(@TeresaSAmaral) 's Twitter Profile Photo

Looking forward to the at where we will show that and status were independent predictive factors in stage IIIC/D/IV pts receiving adjuvant anti-PD-1.
More info here 👇
meetinglibrary.asco.org/record/196674/…

Looking forward to the #posterdiscussion at #ASCO21  where we will show that #TMB and #BRAFmutation status were independent predictive factors in stage IIIC/D/IV #melanoma pts receiving adjuvant anti-PD-1.
More info here 👇
meetinglibrary.asco.org/record/196674/…
account_circle
Ingentium Melanoma(@ingentium_mel) 's Twitter Profile Photo

Compassionate Use Program to Access Trametinib and Dabrafenib for Patients With BRAFmutation-positive Metastatic Melanoma dlvr.it/Rcdw9g

Compassionate Use Program to Access Trametinib and Dabrafenib for Patients With BRAFmutation-positive Metastatic Melanoma dlvr.it/Rcdw9g
account_circle
touchONCOLOGY(@touchONCOLOGY) 's Twitter Profile Photo

Unlocking New Horizons in BRAF-mutant Metastatic Colorectal Cancer!

Dive into our review spotlighting innovative treatment options reshaping the landscape of care.

touchoncology.com/colorectal-can…

Unlocking New Horizons in BRAF-mutant Metastatic Colorectal Cancer! 

Dive into our review spotlighting innovative treatment options reshaping the landscape of care. 

touchoncology.com/colorectal-can…

#ColorectalCancer #BRAFMutation
account_circle
BC Cancer Foundation(@bccancerfdn) 's Twitter Profile Photo

Wider identification of the in patients with will allow doctors, like Dr. Jonathan Loree to identify life-prolonging targeted treatment options for this incurable cancer. Read the findings published in Clinical Cancer Research: bit.ly/3inX8cZ

Wider identification of the #BRAFMutation in patients with #metastatic #coloncancer will allow doctors, like Dr. @jonathanloree to identify life-prolonging targeted treatment options for this incurable cancer. Read the findings published in @CCR_AACR: bit.ly/3inX8cZ
account_circle
Current Oncology(@CurrentOncology) 's Twitter Profile Photo

🗣️New Article
Association of DNA Promoter Methylation and in
by Farzana Jasmine, Briseis Aschebrook-Kilfoy et al

👉mdpi.com/1718-7729/30/3…

🗣️New Article
Association of DNA Promoter Methylation and #BRAFMutation in #ThyroidCancer
by Farzana Jasmine, Briseis Aschebrook-Kilfoy et al

👉mdpi.com/1718-7729/30/3…
account_circle
EuropaWire(@europawire) 's Twitter Profile Photo

Novartis announces EC approval for Tafinlar® (dabrafenib) in combination with Mekinist® (trametinib) for adjuvant treatment of BRAF V600 mutation-positive melanoma news.europawire.eu/novartis-annou…

@Novartis announces EC approval for Tafinlar® (dabrafenib) in combination with Mekinist® (trametinib) for adjuvant treatment of BRAF V600 mutation-positive melanoma news.europawire.eu/novartis-annou… #Tafinlar #dabrafenib #Mekinist #trametinib #melanoma #tumor #inhibitor #BRAFmutation
account_circle
GxP Lang. Services(@GxP_Services) 's Twitter Profile Photo

According to Surveyed EU5 Oncologists Zelboraf Captures 50 Percent Patient Share of the FirstLine BRAFMutation... bit.ly/IFmp1w

account_circle